Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer

Clinical trial NCT04720664 · TERMINATED

Trial details

NCT number: NCT04720664
Sponsor: Georgetown University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastatic Breast Cancer Hormone Receptor Positive Breast Carcinoma

Start date: 2021-09-22
Primary completion: 2023-02-10
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.